Suppr超能文献

肠道菌群失调及其在与手术相关的医学疾病中的作用。

Dysbiome and Its Role in Surgically Relevant Medical Disease.

机构信息

Department of Surgery, Division of Acute Care Surgery, Washington University in St. Lous, St. Louis, Missouri, USA.

Department of Surgery, Division of Trauma, Surgical Critical Care, and Emergency Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Surg Infect (Larchmt). 2023 Apr;24(3):226-231. doi: 10.1089/sur.2023.019.

Abstract

Several surgically relevant conditions are directly or indirectly influenced by the human microbiome. Different microbiomes may be found within, or along, specific organs and intra-organ variation is common. Such variations include those found along the course of the gastrointestinal tract as well as those on different regions of the skin. A variety of physiologic stressors and care interventions may derange the native microbiome. A deranged microbiome is termed a dysbiome and is characterized by decreased diversity and an increase in the proportion of potentially pathogenic organisms; the elaboration of virulence factors coupled with clinical consequences defines a pathobiome. Specific conditions such as colitis, inflammatory bowel disease, obesity, and diabetes mellitus are tightly linked to a dysbiome or pathobiome. Additionally, massive transfusion after injury appears to derange the gastrointestinal microbiome as well. This review explores what is known about these surgically relevant clinical conditions to chart how non-surgical interventions may support surgical undertakings or potentially reduce the need for operation.

摘要

几种与外科手术相关的情况直接或间接地受到人类微生物组的影响。不同的微生物组可能存在于特定器官内部或周围,器官内的变异很常见。这种变异包括胃肠道内的变异以及皮肤不同区域的变异。各种生理应激和护理干预措施可能会扰乱原生微生物组。一个失调的微生物组被称为失调微生物组,其特征是多样性降低,潜在致病生物的比例增加;毒力因子的产生与临床后果相结合定义了病理微生物组。特定疾病,如结肠炎、炎症性肠病、肥胖症和糖尿病,与失调微生物组或病理微生物组密切相关。此外,创伤后大量输血似乎也会扰乱胃肠道微生物组。这篇综述探讨了与外科手术相关的这些临床情况,以阐明非手术干预措施如何支持外科手术或可能减少手术的必要性。

相似文献

1
Dysbiome and Its Role in Surgically Relevant Medical Disease.
Surg Infect (Larchmt). 2023 Apr;24(3):226-231. doi: 10.1089/sur.2023.019.
2
Microbiome Contributions to Health.
Surg Infect (Larchmt). 2023 Apr;24(3):213-219. doi: 10.1089/sur.2023.002.
3
Fecal microbiota transplantation for gastrointestinal disorders.
Curr Opin Gastroenterol. 2017 Jan;33(1):8-13. doi: 10.1097/MOG.0000000000000326.
5
MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Gut Microbes. 2020 Nov 9;12(1):1725220. doi: 10.1080/19490976.2020.1725220. Epub 2020 Mar 4.
6
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.
Nutrients. 2021 May 23;13(6):1780. doi: 10.3390/nu13061780.
7
Microbiome-phage interactions in inflammatory bowel disease.
Clin Microbiol Infect. 2023 Jun;29(6):682-688. doi: 10.1016/j.cmi.2022.08.027. Epub 2022 Oct 1.
8
The Complex Link and Disease Between the Gut Microbiome and the Immune System in Infants.
Front Cell Infect Microbiol. 2022 Jun 15;12:924119. doi: 10.3389/fcimb.2022.924119. eCollection 2022.
9
The gut microbiota and gut disease.
Intern Med J. 2021 Oct;51(10):1594-1604. doi: 10.1111/imj.15520.
10
The microbiome and the immune system in critical illness.
Curr Opin Crit Care. 2021 Apr 1;27(2):157-163. doi: 10.1097/MCC.0000000000000800.

引用本文的文献

1
Looking for the Ideal Probiotic Healing Regime.
Nutrients. 2023 Jul 6;15(13):3055. doi: 10.3390/nu15133055.

本文引用的文献

1
The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660.
Infect Dis Ther. 2023 Jan;12(1):1-7. doi: 10.1007/s40121-022-00714-9. Epub 2022 Nov 7.
2
The central and biodynamic role of gut microbiota in critically ill patients.
Crit Care. 2022 Aug 18;26(1):250. doi: 10.1186/s13054-022-04127-5.
3
The gut microbiome.
Curr Biol. 2022 Mar 28;32(6):R257-R264. doi: 10.1016/j.cub.2022.02.023.
4
Whole blood resuscitation restores intestinal perfusion and influences gut microbiome diversity.
J Trauma Acute Care Surg. 2021 Dec 1;91(6):1002-1009. doi: 10.1097/TA.0000000000003381.
5
The role of the microbiome in diabetes mellitus.
Diabetes Res Clin Pract. 2021 Feb;172:108645. doi: 10.1016/j.diabres.2020.108645. Epub 2020 Dec 24.
6
Defining Microbiome Readiness for Surgery: Dietary Prehabilitation and Stool Biomarkers as Predictive Tools to Improve Outcome.
Ann Surg. 2022 Nov 1;276(5):e361-e369. doi: 10.1097/SLA.0000000000004578. Epub 2020 Nov 4.
7
Association between the gut and oral microbiome with obesity.
Anaerobe. 2021 Aug;70:102248. doi: 10.1016/j.anaerobe.2020.102248. Epub 2020 Aug 14.
8
Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
Gastroenterology. 2020 Nov;159(5):1982-1984. doi: 10.1053/j.gastro.2020.07.045. Epub 2020 Jul 30.
9
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.
Protein Cell. 2021 May;12(5):331-345. doi: 10.1007/s13238-020-00745-3. Epub 2020 Jun 29.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验